Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Eton Pharmaceuticals, Inc. (ETON) had Operating Cash Flow per Share of $0.04 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$39.01M |
|
$-3.82M |
|
$15.60M |
|
$23.41M |
|
$41.61M |
|
$-2.60M |
|
$-1.21M |
|
$-3.81M |
|
$-3.81M |
|
$-3.82M |
|
$-3.82M |
|
$-3.82M |
|
$-3.82M |
|
$-2.60M |
|
$-0.34M |
|
25.89M |
|
25.89M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$41.02M |
|
$0.03M |
|
$35.10M |
|
$76.12M |
|
$19.95M |
|
$29.81M |
|
$31.75M |
|
$51.70M |
|
$24.43M |
|
$-10.45M |
|
$24.43M |
|
26.71M |
|
| Cash Flow Statement Financials | |
$0.97M |
|
$-40.01M |
|
$32.59M |
|
$21.39M |
|
$14.94M |
|
$-6.45M |
|
$3.17M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.06 |
|
-- |
|
-- |
|
0.55 |
|
1.22 |
|
60.01% |
|
-6.66% |
|
-6.66% |
|
-0.88% |
|
-9.76% |
|
-9.80% |
|
$0.94M |
|
-- |
|
-- |
|
-- |
|
0.51 |
|
1.02 |
|
7.28 |
|
50.16 |
|
-15.65% |
|
36.57% |
|
-5.02% |
|
-7.05% |
|
$0.91 |
|
$0.04 |
|
|
Operating Cash Flow per Share |
$0.04 |